Categories
Disease Modifying Anti-rheumatic Drugs,DMARDs Mycophenolate Pharmacology Physiotherapy

Mycophenolate and Infections

In this article we will discuss Mycophenolate and Infections

In this article, we will discuss Mycophenolate and Infections. So, let’s get started.

Mycophenolate and Infections

Oversuppression of the immune system can also increase susceptibility to infection,
including opportunistic infections, fatal infections, and sepsis. In patients receiving
Mycophenolate (2 g or 3 g) in controlled studies for prevention of renal, cardiac or hepatic rejection, fatal infection/sepsis occurred in approximately 2% of renal and cardiac patients and in 5% of hepatic patients.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.